Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE · BSE: 532321 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹1,203.90
Market cap: ₹1,21,141 Cr
Revenue (annual): ₹27,148 Cr
Net profit (annual): ₹5,040 Cr
P/E (TTM): 26.8×Sector 50.4×
Promoter holding: 75.01%+0.01% QoQ
FII holding: 6.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 2 Legal & Regulatory 1 Credit Rating 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

11 Aug 2026 13:22 IST BSE

Financial Results

Zydus Lifesciences Q1 FY27 Results: Net Profit ₹939.8 Cr, Down 35.9% YoY

Zydus Lifesciences Ltd reported revenue from operations of ₹8,017 Cr (+22.0% YoY) and net profit of ₹939.8 Cr (-35.9% YoY) for Q1 FY27.

Key figure: Net profit ₹939.8 Cr · -35.9% YoY

Open full results → Read the filing ↗

19 May 2026 14:08 IST BSE

Financial Results

Zydus Lifesciences Q4 FY26 Results: Net Profit ₹1,272 Cr, Up 8.7% YoY

Zydus Lifesciences Ltd reported revenue from operations of ₹7,587 Cr (+16.2% YoY) and net profit of ₹1,272 Cr (+8.7% YoY) for Q4 FY26.

Key figure: Net profit ₹1,272 Cr · +8.7% YoY

Open full results → Read the filing ↗